From the June 2021 issue of HealthCare Business News magazine
By Edward Rodriguez
It’s projected that the molecular imaging market will grow at a CAGR of 5.7% and reach $5.855 billion by 2025.
One of the driving factors is the development of new PET and SPECT radiopharmaceuticals. Molecular imaging providers have begun to increase their services as COVID-19 vaccinations are more accessible. They have also used COVID-19 financial assistance for qualified capital, which in turn provides them the flexibility to shift “excess” dollars to non-qualifiable capital.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
During the past 12 months in molecular imaging capital, there has been strong activity, with:
• 44% of interest shown in single-photon emission computerized tomography (SPECT) imaging systems
• 20% in positron emission tomography/computed tomography (PET/CT)
• 18% in both nuclear medicine CT imaging systems and specialty systems (e.g., cardiac)
To date, GE Healthcare is the most active supplier in the molecular imaging market, with a 61% quote frequency, followed by Siemens Healthineers with a 31% frequency, Philips with a 6% frequency, and Canon with a 2% frequency.
When looking at the SPECT market, GE’s NM 830 imaging system has been the most active, with an average purchase price (APP) of $240,000 and a 65% frequency. Siemens’ most active system is its Symbia Evo, with an APP of $264,000 and a 31% frequency. Siemens also offers the Symbia Intevo Excel in this market, with an APP of $436,000 and a 4% frequency. Although there are a few other offerings in the market, the imaging systems cited are the most active.
Previously, nuclear medicine systems have been the second most frequent quotes submitted by our client members for analysis. However, in the last 12 months PET/CT has been the second most active, including both the 16 to 40 and 64 to 128-slice supplier solutions. The most active suppliers, in no particular order, are Siemens, GE, Philips, and Canon.
In the 16 to 40 slice market, the data show GE’s solutions as being the most active, with a 58% frequency, followed by Siemens with a 33% frequency, and Canon with an 8% frequency. GE’s Discovery MI Digital Ready imaging system has an APP of $1.28 million and its Discovery IQ 3 Ring system has an APP of $1.07 million. Siemens has two offerings most often requested by clients: the Biograph mCT-s (40) and the Biograph Horizon, with APPs of $1.71 million and $1.25 million, respectively. Canon offers the Celesteion large-bore system, with an APP of $1.17 million.
In the 64 to 128-slice market, three suppliers are most active in PET/CT: Siemens with a 56% frequency, GE with a 33% frequency, and Philips with an 11% frequency. This market sector reflects the most activity in two offerings from Siemens: the Biograph mCT-s (64) system with an AP of $1.36 million and the Biograph Vision 450 with an APP of $1.61 million. Clients have also considered two GE solutions: the Discovery MI 3 Ring, with an APP of $1.87 million, and the Discovery 5 Ring system, with an APP of $3.29 million. The Vereos system from Philips has an APP of $1.72 million.